CRISTALLI, Gloria
 Distribuzione geografica
Continente #
NA - Nord America 17.252
EU - Europa 6.314
AS - Asia 6.008
SA - Sud America 786
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 46
OC - Oceania 8
Totale 30.599
Nazione #
US - Stati Uniti d'America 16.621
CN - Cina 2.630
SG - Singapore 1.814
RU - Federazione Russa 1.627
DE - Germania 863
IT - Italia 811
BR - Brasile 679
SE - Svezia 562
CA - Canada 555
GB - Regno Unito 527
UA - Ucraina 524
FR - Francia 517
HK - Hong Kong 473
VN - Vietnam 354
FI - Finlandia 302
PL - Polonia 239
TR - Turchia 190
KR - Corea 180
ZA - Sudafrica 135
IE - Irlanda 116
IN - India 79
JP - Giappone 52
MX - Messico 49
EU - Europa 45
BE - Belgio 39
AR - Argentina 37
BD - Bangladesh 37
ES - Italia 37
CZ - Repubblica Ceca 36
IQ - Iraq 32
NL - Olanda 30
IR - Iran 29
VE - Venezuela 23
UZ - Uzbekistan 19
EC - Ecuador 14
RO - Romania 14
KE - Kenya 13
ID - Indonesia 12
SA - Arabia Saudita 12
MA - Marocco 11
AE - Emirati Arabi Uniti 10
AT - Austria 10
CL - Cile 10
IL - Israele 9
LT - Lituania 9
PK - Pakistan 9
PY - Paraguay 9
AZ - Azerbaigian 8
CO - Colombia 8
JO - Giordania 8
CH - Svizzera 7
PH - Filippine 7
RS - Serbia 7
NP - Nepal 6
TN - Tunisia 6
DZ - Algeria 5
MY - Malesia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
JM - Giamaica 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AL - Albania 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
GT - Guatemala 2
KH - Cambogia 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
Totale 30.581
Città #
Woodbridge 1.513
Fairfield 1.481
Jacksonville 1.352
Ashburn 1.334
Houston 1.047
Chandler 1.043
Singapore 926
San Jose 772
Wilmington 680
Seattle 668
Ann Arbor 641
Boardman 521
Nanjing 510
Cambridge 498
Hong Kong 466
Beijing 358
Toronto 342
The Dalles 276
Dallas 250
Dearborn 216
San Mateo 207
Los Angeles 202
Düsseldorf 196
Columbus 192
Kraków 189
Seoul 177
Council Bluffs 171
Princeton 170
Lawrence 169
Tongling 169
New York 162
Lachine 155
Lauterbourg 153
Istanbul 149
Nanchang 147
Ogden 143
Buffalo 130
Johannesburg 122
Dublin 116
Moscow 115
Helsinki 108
Ho Chi Minh City 102
Shenyang 92
London 91
Hanoi 87
Kunming 83
Guangzhou 79
Tianjin 78
Hebei 76
Milan 75
Shanghai 73
Chicago 72
San Diego 71
Santa Clara 70
São Paulo 61
Jiaxing 58
Camerino 49
Frankfurt am Main 49
Munich 48
Orem 47
Tokyo 47
Venezia 47
Jinan 45
Brussels 39
Changsha 38
Ningbo 37
Warsaw 37
Stockholm 36
Wuhan 35
Denver 30
Hangzhou 30
Atlanta 29
Boston 28
Hefei 28
Orange 28
Redwood City 28
Zhengzhou 28
Brooklyn 27
Philadelphia 25
Detroit 24
Falls Church 24
Mexico City 24
Montreal 24
Phoenix 24
Verona 24
Brno 23
Kocaeli 23
Taizhou 22
Chennai 21
Da Nang 21
Lanzhou 21
Norwalk 21
Venice 21
Washington 21
Auburn Hills 20
Leawood 19
Nürnberg 19
Poplar 19
Bremen 18
Manchester 18
Totale 20.690
Nome #
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 297
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones 289
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 274
2-Aralkynyl and 2-Heteroalkynyl derivatives of Adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists 268
A preliminary matrix-assisted laser desorption/ionization time-of-flight approach for the characterization of Italian lentil varieties 263
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 262
2-Substituted N-ethylcarboxamidoadenosine derivatives as high affinity agonists at human A(3) adenosine receptors 259
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors 251
Functional properties of subunit interactions in human cytidine deaminase 249
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 248
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 247
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 247
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 243
2-Alkynyl derivatives of Adenosine-5'-N-ethyluronamide (NECA): selective A2 adenosine receptor agonists with potent inhibitory activity on Platelet aggregation 242
Human cytidine deaminase: understanding the catalytic mechanism 239
Inhibition studies on membrane Adenosine Deaminase from human placenta 238
Synthesis and evaluation of hexitol nucleoside congeners as ambiguous nucleosides 237
Determination of ink photoinitiators in packaged beverages by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry 237
Composition and biological activity of essential oil of Achillea ligustica All. (Asteraceae) naturalized in central Italy: ideal candidate for anti-cariogenic formulations 235
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 233
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 233
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 232
Simultaneous Determination of Squalene, α-Tocopherol and β-Carotene in Table Olives by Solid Phase Extraction and High-Performance Liquid Chromatography with Diode Array Detection 232
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 231
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 230
Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y(1) receptor antagonists and partial agonists 228
Complex of dipeptidyl peptidase II with adenosine deaminase. 228
Comparative study of aroma profile and phenolic content of Montepulciano monovarietal red wines from the Marches and Abruzzo Regions of Italy using HS-SPME-GC-MS and HPLC-MS 225
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 223
Adenosine deaminase: Functional implications and different classes of inhibitors 223
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles 223
Optimization of espresso machine parameters through the analysis of coffee odorants by HS-SPME–GC/MS 222
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 220
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 218
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 217
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 217
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors 215
CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. 214
Antiviral properties of deazaadenine nucleoside derivatives 214
Strong enhancement of vibrational relaxation by Watson-Crick base pairing 211
Glandular trichomes and essential oil composition of endemic Sideritis italica (Mill.) Greuter et Burdet from central Italy 211
"N-Cycloalkylalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists at the A1 adenosine receptor 210
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 210
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 210
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 208
Purification of human cytidine deaminase : Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs 207
2- And 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosines receptors 206
2-phenylhydroxypropynyladenosine derivatives as high potent agonists at A(2B) adenosine receptor subtype 204
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 204
Adenosine receptor modeling: what does the A2A crystal structure tell us? 204
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 204
Diazepinone nucleosides as inhibitors of cytidine deaminase 203
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 203
Functional residues at the active site of bovine brain adenosine deaminase. 203
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 202
Further studies on intersubunit interactions in human cytidine deaminase 200
Essential oil from fruits and roots of Ferulago campestris (Apiaceae): composition and antioxidant and anti-Candida activity 200
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 198
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 198
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 196
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 196
Alkannin/shikonin mixture from roots of Onosma echioides (L.) L.: Extraction method study and quantification 195
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 195
2-ChloroATP exerts anti-tumoral actions not mediated by P2 receptors in neuronal and glial cells line 193
Chemical and pharmacological profile of selective adenosine receptor agonists 193
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 193
Unexpected synthesis of acyclic adenine nucleosides 191
Synthesis and receptor affinity of polysubstituted adenosines 191
Kinetic and structural analysis of the inhibition of adenosine deaminase by acetaminophen 190
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 189
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 189
Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2',3'-didehydro-2',3'-dideoxy-3-deazaadenosine, 2',3'-dideoxy-3-deazaadenosine and some 2',3'-dideoxy-3-deazaadenosine 5'-dialkyl phosphates 188
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 188
Adenosine deaminase inhibitors: structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogs 187
Potent and selective ligands for adenosine binding sites 186
[3H]HEMADO – a novel tritiated agonist selective for the human adenosine A(3) receptor 186
Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity 185
Volatile components in whole and different plant parts of Bastard Balm (Melittis melissophyllum L, Lamiaceae) collected in central Italy and Slovakia 184
A2A adenosine receptor antagonists 183
A(2B) adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyladenosine and NECA derivatives 183
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution result in distinct selectivities. 183
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 183
Chemical differences in volatiles between Melittis melissophyllum L subsp melissophyllum and subsp albida (Guss) PW Ball (Lamiaceae) determined by solid phase microextraction (SPME) coupled to GC/FID and GC/MS 182
Cytidine dEaminase from human placenta 182
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide 181
Photoinactivation studies on adenosine deaminase 181
Synthesis and adenosine deaminase inhibitory activity of 3’-deoxy-1-deazaadenosines 181
A2A adenosine receptor antagonists 180
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A1 adenosine receptor 179
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists 177
Synthesis, structure-affinity relationships and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 177
Coupling of 2,6-disubstituted purines to ribose-modified sugars 176
N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands 176
Well water in central Italy: Analysis of herbicide residues as potential pollutants of untreated crops 176
Synthesis and stability studies of 2 ',3 ',5 '-tri-O-acetyl-2-amino(-N-6-cyclopentyl)-1-deazaadenosines 176
Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues 176
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies 176
Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine 175
Coupling of 2,6-dichloropurine and 2,6-dichlorodeazapurines with ribose and ribose modified sugars 173
Structure-activity relationships of adenosine deaminase inhibitors 173
Totale 20.943
Categoria #
all - tutte 120.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 0 0 0 0 0 0 0 0 343
2021/20221.875 188 457 33 95 126 116 67 140 127 206 106 214
2022/20232.475 225 87 72 422 314 375 3 160 489 122 154 52
2023/20241.542 260 92 90 51 73 168 43 46 169 36 16 498
2024/20254.981 150 147 448 239 149 300 541 1.260 379 353 243 772
2025/20266.363 441 390 648 935 799 550 1.197 372 284 397 299 51
Totale 30.820